We also noted that the glycolysis enzyme ENO1, which was transcriptionally enriched in the noninvasive phenotype and has been a target of interest for cancer drug development, has recently been shown to have an iron-regulatory role via modulating the degradation of ACO1.66 This evidence concerns the gene ENO1 and cancer.